BUSINESS MEETING Although EBNEO is still operating during its first year we will run a shortened Annual Business Meeting during the EBNEO conference, 5.30 PM, 10 September. Hope to see you there!
REACHING OUT Is it very nice to see how EBNEO is developing and how the digital footprint becomes larger and larger! All curves about memberships, followers and subscribers point upwards!
CAFFEINE Caffeine is a common therapy for apnea of prematurity; however, its long-term outcomes as a prophylactic treatment are unknown. This observational study assessed outcomes of early or late caffeine administration in premature neonates and found that early caffeine administration (<3 days of life) is associated with improved outcomes. These findings should be further studied in a randomized controlled trial before caffeine can be recommended as a prophylactic therapy.